Report | Smart Manufacturing in 2026: Technology, Trends, and Insights for CMOs

If you’re managing external manufacturing today, technology is already shaping your risk, your timelines, and your relationships with CMOs and CDMOs. Digital maturity gaps, uneven automation, and rising regulatory expectations mean that how your partners invest in technology now directly impacts supply resilience and quality outcomes.

This technology report gives you a clear view of how smart manufacturing, AI, automation, and digital quality systems are reshaping pharma contract manufacturing, and what this means for your CMO strategy in the year ahead.

Download this report to understand:

• Which manufacturing technologies are genuinely improving reliability, compliance, and capacity
• How digitalisation is changing pharma–CMO collaboration, visibility, and decision-making
• Where technology gaps in your supply network could become future risk     

This report sets the context for the conversations happening at Pharma Contract Manufacturing 2026 (23–25 March, Berlin), where pharma and CMO leaders will go deeper into how technology, partnerships, and capacity planning must evolve together under pressure.

Download the report now, and come to PCM 2026 ready to challenge assumptions, benchmark your partners, and engage in more informed, practical discussions with your manufacturing network.